NHC NATIONAL HEALTHCARE CORP revenue, earnings and financials

For the quarter ended June 30, 2026, NATIONAL HEALTHCARE CORP reported revenue of $408M (up 8.8% from a year earlier), net income of $40.3M and diluted EPS of $2.54; over the last four quarters revenue was $1.56B and net income $140M; for the fiscal year ended December 2025 revenue was $1.52B, up 16.1% on the year before.

NHC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.52B, gross profit n/a, operating income $128M, net income $120M (margin 7.9%), EPS $7.67
• Fiscal year ended Dec 2024: revenue $1.31B, gross profit n/a, operating income $89.9M, net income $102M (margin 7.8%), EPS $6.53
• Fiscal year ended Dec 2023: revenue $1.14B, gross profit n/a, operating income $57.5M, net income $66.8M (margin 5.9%), EPS $4.34
• Fiscal year ended Dec 2022: revenue $1.09B, gross profit n/a, operating income $31.9M, net income $22.4M (margin 2.1%), EPS $1.45
• Fiscal year ended Dec 2021: revenue $1.07B, gross profit n/a, operating income $50.9M, net income $139M (margin 12.9%), EPS $8.99

NHC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $408M (up 8.8% year over year), net income $40.3M, EPS $2.54
• Quarter ended Mar 31, 2026: revenue $382M (up 2.2% year over year), net income $35.9M, EPS $2.27
• Quarter ended Dec 31, 2025 (from the annual report): revenue $387M (up 4.6% year over year), net income $24.8M, EPS $1.58
• Quarter ended Sep 30, 2025: revenue $383M (up 12.5% year over year), net income $39.2M, EPS $2.50
• Quarter ended Jun 30, 2025: revenue $375M (up 24.7% year over year), net income $23.7M, EPS $1.52
• Quarter ended Mar 31, 2025: revenue $374M (up 25.7% year over year), net income $32.2M, EPS $2.07
• Quarter ended Dec 31, 2024 (from the annual report): revenue $369M (up 22.7% year over year), net income $6.08M, EPS $0.38
• Quarter ended Sep 30, 2024: revenue $340M (up 17.9% year over year), net income $42.8M, EPS $2.73
• Quarter ended Jun 30, 2024: revenue $301M (up 6.4% year over year), net income $26.8M, EPS $1.73
• Quarter ended Mar 31, 2024: revenue $297M (up 10.2% year over year), net income $26.2M, EPS $1.69
• Quarter ended Dec 31, 2023 (from the annual report): revenue $301M (up 13.7% year over year), net income $28.4M, EPS $1.84
• Quarter ended Sep 30, 2023: revenue $288M (up 6.5% year over year), net income $10.4M, EPS $0.68
• Quarter ended Jun 30, 2023: revenue $283M (up 4.1% year over year), net income $16.3M, EPS $1.06
• Quarter ended Mar 31, 2023: revenue $270M (down 3.4% year over year), net income $11.7M, EPS $0.76
• Quarter ended Dec 31, 2022 (from the annual report): revenue $265M (down 6.7% year over year), net income $6.35M, EPS $0.41
• Quarter ended Sep 30, 2022: revenue $271M (down 2.1% year over year), net income −$2.43M, EPS −$0.16
• Quarter ended Jun 30, 2022: revenue $271M (up 3.1% year over year), net income $3.20M, EPS $0.21
• Quarter ended Mar 31, 2022: revenue $279M (up 11.2% year over year), net income $15.3M, EPS $0.99
• Quarter ended Dec 31, 2021 (from the annual report): revenue $283M, net income $15.8M, EPS $1.03
• Quarter ended Sep 30, 2021: revenue $277M, net income −$3.35M, EPS −$0.22

NHC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $185M, share buybacks $14.7M, dividends $2.53 per share
• Fiscal year ended Dec 2024: operating cash flow $107M, share buybacks $13.5M, dividends $2.42 per share
• Fiscal year ended Dec 2023: operating cash flow $111M, share buybacks $2.48M, dividends $2.34 per share
• Fiscal year ended Dec 2022: operating cash flow $8.74M, share buybacks $9.90M, dividends $2.26 per share
• Fiscal year ended Dec 2021: operating cash flow $62.4M, share buybacks $836K, dividends $2.11 per share

NHC balance sheet

• Jun 30, 2026: cash $39.2M, total assets $1.54B, total liabilities $409M, shareholders' equity $1.12B, long-term debt $0
• Mar 31, 2026: cash $85.5M, total assets $1.52B, total liabilities $427M, shareholders' equity $1.09B, long-term debt $0
• Dec 31, 2025: cash $92.8M, total assets $1.53B, total liabilities $452M, shareholders' equity $1.07B, long-term debt $32.5M
• Sep 30, 2025: cash $131M, total assets $1.57B, total liabilities $514M, shareholders' equity $1.05B, long-term debt $65.6M
• Jun 30, 2025: cash $111M, total assets $1.56B, total liabilities $537M, shareholders' equity $1.02B, long-term debt $103M
• Mar 31, 2025: cash $90.4M, total assets $1.55B, total liabilities $541M, shareholders' equity $1.00B, long-term debt $127M
• Dec 31, 2024: cash $76.1M, total assets $1.52B, total liabilities $541M, shareholders' equity $980M, long-term debt $130M
• Sep 30, 2024: cash $84.8M, total assets $1.56B, total liabilities $576M, shareholders' equity $983M, long-term debt $130M

What is NHC's revenue?

NATIONAL HEALTHCARE CORP reported $1.56B of revenue over its last four quarters, through June 30, 2026.

Is NHC profitable?

Yes. NATIONAL HEALTHCARE CORP earned $140M over the last four quarters.

What is NHC's EPS?

Diluted earnings per share over the last four quarters were $8.89; $2.54 in the latest quarter.

Does NHC pay a dividend?

NATIONAL HEALTHCARE CORP paid $2.53 per share in dividends in the fiscal year ended December 2025.

NHC ownership and insider trades · All stocks